SMMT
Summit Therapeutics PLC
16.50$
-3.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.0% | -95.5% | -25.9% | 0.0% | +74,603.7% | -99.8% | +48.0% | – | – | +910.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +55.0% | +25.7% | +48.1% | -22.1% | +45.5% | -3.3% | +230.4% | +0.0% | +12.4% | -10.0% | +18.9% | – | |
| – | +103.9% | +0.5% | +19.7% | +39.6% | -24.4% | +4.6% | +754.7% | +0.0% | -24.8% | -19.3% | +0.3% | – | |
| – | +69.1% | +18.3% | +40.4% | -7.4% | +20.0% | -1.3% | +352.6% | +0.0% | -4.0% | -13.2% | +13.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.4% | +7.7% | -0.6% | -20.9% | -99.6% | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -105.1% | – | -90.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.